Oramed Pharmaceuticals Inc (ORMP) — Long-term Investment Intensity
Oramed Pharmaceuticals Inc (ORMP) has a Long-term Investment Intensity of 96.0% as of December 2025. Long-term investments of $93.74 Million represent 96.0% of total assets of $97.59 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Oramed Pharmaceuticals Inc (ORMP) shareholders funds for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Oramed Pharmaceuticals Inc Long-term Investment Intensity (2020–2025)
This chart shows how Oramed Pharmaceuticals Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the intensity stands at 96.0%, reflecting long-term investments of $93.74 Million against total assets of $97.59 Million USD. Also explore balance sheet size of Oramed Pharmaceuticals Inc for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Oramed Pharmaceuticals Inc (2020–2025)
The table below presents the year-by-year Long-term Investment Intensity for Oramed Pharmaceuticals Inc from 2020 to 2025, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Oramed Pharmaceuticals Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 96.0% | $93.74 Million | $97.59 Million | ▲ +89.0 pp |
| 2024 | 7.0% | $10.91 Million | $155.28 Million | ▼ -17.9 pp |
| 2023 | 24.9% | $54.93 Million | $220.55 Million | ▲ +23.2 pp |
| 2022 | 1.7% | $2.70 Million | $161.64 Million | ▼ -3.6 pp |
| 2021 | 5.2% | $6.69 Million | $128.00 Million | ▼ -3.6 pp |
| 2020 | 8.8% | $3.93 Million | $44.63 Million | — |